Amongst its metabolic effects, hGH can induce inhibition of lipoprotein lipase activity in adipose tissue, stimulating lipolysis in adipocytes, which results in the reduction of fat cell mass [4-7]. Moreover, a correlation has been found between adiposity and the reduced circulating levels of hGH [8]. When applied systemically, hGH reduces body fat mass and influences fat distribution [9]. Therefore, treatment with hGH should theoretically have a positive impact on obesity. However, long term treatment with hGH is associated with various health risks, including glucose intolerance and insulin resistance, diabetes, acromegaly, cancer, edema, and hypertension [10-13].
Two submissions supported the proposal as advertising was considered to bring important benefits in terms of better information for consumers on the availability of a combination product with rapid and effective pain relief and reduced doses of analgesic. Responsible advertising will alert consumers that combination products are available from pharmacies with advice from the pharmacist. One submission opposed the proposal as it was believed that there would be no benefit to the consumer by amending Appendix H to include a new entry for paracetamol/ibuprofen.
LR3 would be great for fatloss. I would use that solo (not with cjcdac or gh)... obviously if you have any clen, t3, eca etc then you could add them in. I have limited experience with lr3 so can't fully comment from my own research. But from what I observed on Bane it is great for fatloss... anything that raises igf-1 should be. But the results from the cjc-dac were superior in every way during my research.
Prolonged use of intact hGH may result in negative effects on glucose metabolism, such as glucose intolerance and insulin resistance. Given that AOD9604 is a peptide fragment of the C-terminus of hGH, its effect on glucose control was monitored. OGTT testing was carried out on all patients during the screening phase as well as at various time points during the treatment period. No significant changes or obvious trends in the OGTT in any treatment group were observed, suggesting that AOD9604 supplementation does not deteriorate glucose control or induce insulin resistance. In contrast, treatment with AOD9604 seemed to have a positive effect in subjects with impaired glucose tolerance. In the 12 weeks treatment study, patients with impaired glucose tolerance supplemented with AOD9604 were less likely to develop diabetes during the study than subjects taking placebo. This hypothesis, however, has to be confirmed in a separate clinical trial. In contrast, in a recent clinical trial of hGH effects in obese women, hGH caused an increase in IGF-1 levels over a 6 month dosing period and decreased glucose tolerance in a subset of trial participants [29].
However, both the original GRF (1-29) and the Mod GRF 1-29 required frequent dosages. So a new compound called CJC-1295 was created which was far more stable. This compound was made by adding Lysine – which is a non-peptide, and is also called Drug Affinity Complex or DAC. Since the original Mod GRF 1-29 does not contain DAC, it is named as CJC-1295 without DAC. However, the actual CJC-1295 is not only difficult, but also very expensive to produce. This is why it is not produced or used extensively. The Mod GRF 1-29 is far easier and cheaper to produce.

Figure 1. A, Concentrations of plasma mature ANP levels at baseline and at 40, 80, 120, and 180 minutes after the start of saline infusion. Solid line with squares represents pre‐bypass surgery subjects and dotted line with triangles represents post‐bypass surgery subjects. B, Concentrations of plasma Nt‐proANP levels at baseline and at 40, 80, 120, and 180 minutes after the start of saline infusion. Solid line with squares represents pre‐bypass surgery subjects and dotted line with triangles represents post‐bypass surgery subjects. ANP indicates atrial natriuretic peptide; Nt‐proANP, N‐terminal pro‐ANP.
A similar clinical study was conducted in obese subjects (METAOD002). In that double-blind placebo-controlled, 4 sequence, 4 period William’s Latin Square design study 23 subjects participated. The subjects were 19 to 50 years old and had a BMI ≥ 35 kg/m2 (range 36 to 67 kg/m2). Each subject received 4 single doses (25, 50 and 100 µg/kg AOD9604 or placebo; single IV infusion doses over 20 minutes), separated by a 7-day washout period.

Over the last 40 years a lot of research has been done on various peptides developing new peptide sequences to produce new peptides with fewer side effects and new beneficial effects. For example fragments of the growth hormone peptide have been developed such as AOD 9604 which possess all the fat burning properties of growth hormone without any of its adverse effects on blood sugar or growth.

GH levels decrease significantly as one ages. By the time you are 30 years old the endocrine system is no longer functioning optimally, thus the hormones that typically helped us stay lean, are secreting at a much lower level. The result of this is stubborn fat storage, which favours the abdominal region. Visceral fat in particular is a very common plight in middle age.

CJC 1295 can be compounded in two forms (DAC and non-DAC). Drug affinity complex (DAC) prevents enzymatic degradation thus increasing the half-life. Consequently CJC 1295-DAC can be dosed as a single weekly injection. Administration of CJC 1295-DAC provides a GHRH-like stimulation around the clock. A potential drawback when using a weekly protocol can be attributed to ineffective GHRH stimulation when the body is due for a GH spike (usually 1:00am). This is referred to as a GH-bleed and the overall result is inferior to using CJC 1295-NON-DAC daily for 5 days out of 7. Therefore using CJC 1295-NON-DAC daily (between 6-8pm) provides a more effective GH spike at 1:00am.
Paracetamol has long been considered very safe, without the risks of gastric injury associated with aspirin and NSAIDs. But there are distinct risks of liver injury, usually following overdose situations. In response many international regulatory authorities have taken steps to reduce the pack sizes of paracetamol, and to restrict release in some environments to pharmacies. In the USA, FDA has required prescription acetaminophen, when it is usually combined with an opioid, to reduce the dose per dose unit to 325 mg, but without reducing the maximal daily dose. No change of dosing in the USA has yet come for OTC acetaminophen. Use of paracetamol should be kept to a minimum in patients with underlying liver and renal disease. It can reduce the effects of lithium, ACE inhibitors, beta blockers and methotrexate. However, it remains one of the safest and most effective analgesic drugs, particularly in the elderly where the risks of gastric bleeding with NSAIDs are more common, and carries minimal side effects.
Experimental animals were anesthetized with an intramuscular injection of xylazine (Rompun®; Bayer Co., Seoul, Korea) at a dose of 1.9 mg/kg and ketamine (Ketar®; Yuhan Co., Seoul, Korea) at a dose of 46 mg/kg. The right knee joints of all rabbits were shaved and sterilized. Then, 2 mg of collagenase type II from Clostridium histolyticum (Sigma Co., St. Louis, MO, USA) was prepared for intra-articular injection. Collagenase was dissolved in a sterile phosphate buffered saline (pH 7.4) and filtered with a 0.22-μm membrane. The solution was slowly injected into the right knee joint using ultrasound guidance. The same injection was repeated 3 days after the first injection, as previously reported (Figure 1) [8].
Conclusions: Subcutaneous administration of CJC 1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, particularly at doses of 30 or 60 ug/ kg. There was evidence of a cumulative effect after multiple doses. These data support the potential utility of CJC 1295 as a therapeutic agent.
Example 2 - Morning Injection ◦Wake up and inject your HGH Frag 176-191 (250mcg to 500mcg is a good dosage depending on your budget). ◦Wait as long as possible before having your first meal (the longer you wait the more fat you will burn). ◦When you do eat, try to make the meal high protein, low fat and low carbohydrate (example meat and salad/vegetables). ◦If possible, try to do some cardio in the hours after your injection to increase the fat burning effect.
In this paper, we investigated whether the changes observed inβ 3-AR RNA expression in vitro also occur in an in vivo model. The in vivo model used was the obese (ob/ob) mouse model of obesity that has repressed levels of β3-ARs, which in part contributes to reduced lipolytic sensitivity (12). Lean C57BL/6J mice were used as a control. Following a 14-d chronic administration with AOD9604 or hGH, adipose tissue weights were measured, and β3-AR mRNA expression was determined. The decrease in weight of adipose tissue depots in the ob/ob mice was associated with increasedβ 3-AR expression. Further studies inβ 3-AR knock-out (β3-KO) mice showed that the presence of the β3-AR is necessary to mediate the chronic effectiveness of hGH and AOD9604 with regards to weight loss and fat mass reduction. However, an acute dose of AOD9604 was capable of increasing energy expenditure inβ 3-KO mice, although the response was less than that seen in the wild-type control mice.
Our Doctor is available for consultations by appointment and can be made by contacting the support team. Our consultation, advice and support is 100% obligation free. All of our Peptides are prescribed by experienced Anti Ageing Doctors. They are then compounded at one of our Australian pharmacies and then shipped Australia wide to Brisbane, Sydney, Melbourne, Hobart, Adelaide, Darwin, Perth and all regional areas.
In this study, AOD9604 was given in a dose of 0.25 mg that is comparable to the dose used in a previous report [8] on GH in promoting recovery to normal walking and in joint repair in the rabbit collagenase model of osteoarthritis. AOD9604 is a fragment of GH; therefore the dose of AOD9604 used was the molar equivalent of the active GH dose that the previous study [8] used. Human GH was given as 3 mg in 0.6 ml intra-articular injection volume. On a molar basis, 3 mg of GH equates to 0.25 mg of AOD9604. In addition, published data [10] suggest that the volume of synovial fluid in an arthritic rabbit is approximately 0.7 ml. Combined with the injection volume, this gives a total volume of 1.3 ml and therefore an initial concentration of AOD9604 of 0.19 mg/ml. In a previous study [11] of GH in the beagle after intra-articular injection, researchers injected 1.5 mg of GH in aqueous solution in 0.15 ml volume. The aqueous formulation gave an initial concentration of approximately 200–300 ug/mL in the synovial fluid. On a molar equivalent basis this equates to 0.11 mg/mL of AOD9604, which is close to the value used in this study.
At Ageing Solutions, we believe in providing you the supplementation, medication, and support to help you stick to your health and fitness resolutions. Our team of highly experienced Physicians and Compounding Pharmacists as well as our Senior Scientist have developed our Medical Weight Loss Programs to provide you with the right medication and detailed food/nutrient programs to help you kick start your weight loss goals.
Experimental animals were anesthetized with an intramuscular injection of xylazine (Rompun®; Bayer Co., Seoul, Korea) at a dose of 1.9 mg/kg and ketamine (Ketar®; Yuhan Co., Seoul, Korea) at a dose of 46 mg/kg. The right knee joints of all rabbits were shaved and sterilized. Then, 2 mg of collagenase type II from Clostridium histolyticum (Sigma Co., St. Louis, MO, USA) was prepared for intra-articular injection. Collagenase was dissolved in a sterile phosphate buffered saline (pH 7.4) and filtered with a 0.22-μm membrane. The solution was slowly injected into the right knee joint using ultrasound guidance. The same injection was repeated 3 days after the first injection, as previously reported (Figure 1) [8].
ASADA gave advice to the ACC, and perhaps Essendon, that AOD-9604 was not banned under the S2 category. Given the expectation that AOD-9604 would not be anabolic because it lacked the ''anabolic region'' of HGH, it is perhaps understandable that ASADA did not classify it under S2 in 2011 and 2012, although its close structural relationship to the banned HGH should have been sufficient to include it on the banned list.
Resting plasma concentrations of mature BNP and Nt‐proBNP were 14±3 pg/mL and 42±9 pg/mL before gastric bypass surgery and increased to 32±5 pg/mL and 107±20 pg/mL (increased by 50% and 31%), respectively (P=0.0009 and 0.0001) after the surgery. Circulating BNP and Nt‐proBNP concentrations during saline infusion were also higher after surgery compared with before surgery (Figures 2A and 2B; P<0.0001). The saline infusion itself was not associated with an increase in BNP or Nt‐proBNP levels at either visit (P=0.65 and 0.60, respectively).

Results: After a single injection of CJC 1295, there were dose dependent increases in mean plasma GH concentrations by 2- to 10-fold for 6 d or more and in mean plasma IGF-I concentrations by 1.5- to 3-fold for 9–11 d. The estimated half-life of CJC 1295 was 5.8–8.1 d. After multiple CJC 1295 doses, mean IGF-I levels remained above baseline for up to 28 d. No serious adverse reactions were reported.
Idealboost is an easy-to-use on-the-go drink packet from Idealshape, the company that brought us the best-selling meal replacement shakes. Idealboost is a simple powder designed to improve weight-loss efforts by blocking hunger, accelerating fat burning, and improving overall energy. The small packets are perfect for adding a little flavor to your water bottle and keeping on top of weight loss on the go! Read More
There were no significant changes in IGF-1 values observed during 24 hours following any AOD9604 dose compared with placebo. No significant differences in glucose levels were observed following AOD9604 administration compared with placebo with the exception of one isolated time point (8% increase 12 hour post treatment in one subject receiving 54 mg AOD09604). There were no clinically significant observable trends in vital signs, physical examinations, abnormalities noted in the ECG measurements, or findings in the safety-related laboratory tests throughout the study.
When using any GHRH, it should always be remembered that positive results cannot be achieved overnight. These compounds act steadily over time, and the best results can be achieved slowly, and with a nutritious diet and a proper exercise regime. Also, these peptides are not sex-specific, so they do not have any androgenic effects. They can be used by women in the same dosages that men do.
Specifically, T α 1 has been shown to enhance the function of certain immune cells called T and dendritic cells. This is very important to anyone with a depressed immune system or suffering from an infection, as these white blood cells play pivotal roles in the body’s defense process. T cells, for example, come in two forms: killer and helper T cells. Killer T cells are responsible for hunting down and destroying our body’s own cells that are cancerous or infected with bacteria or viruses. Helper cells work with the other cells of the immune system to orchestrate and carry out appropriate immune responses.
Hey Elvia, do you think that using DAC for short periods of time at your proposed dose is still effective for fat loss? Say for four weeks at 4mg a week? I know peptides need to be used for awhile before effect can be seen. I was thinking about doing 4mg a week for 4 weeks with Injectable l-carnitine for my last 4 weeks before summer haha. In your experience is it worth it to spend the money on the DAC for such a short period?
The diet program combines medically scripted weight loss medication with specifically formulated Ketogenic supplements to help you control your appetite and switch your body into Ketosis – your body’s fat burning mode. The diet plan comes with a detailed booklet which steps your through the 30-day program, and includes a shopping list, recipes, KetoMed RX program specifics as well as other helpful resources.
Actually, it's under S0 because it is not approved for human use by any regulating authority anywhere. The S2 category is the one relating to mimicking effects of other compounds or GH. But you were right, the OP is fundamentally incorrect. The real reasons that Dank chose this compound to administer to Essendon players is still a mystery but we can be certain it wasn't paid for or administered for the fun of it.
The natriuretic peptide system, the primary salt‐excreting system in humans, acts as an endogenous antagonist of the renin‐angiotensin‐aldosterone system.9 The primary circulating natriuretic peptides are atrial natriuretic peptide (ANP) and B‐type natriuretic peptide (BNP).10 ANP is produced primarily in the atria, while BNP is derived from both the atria and the ventricles.10, 11
As it is not yet approved for use in this country (or any other), it should always have been considered banned under the S0 category, which states that any pharmacological substance that is not addressed by any of the subsequent sections of the Prohibited List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g. drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited.
Prior studies have been largely observational, and based on measurement of natriuretic peptide levels collected in individuals with random salt intake. Because natriuretic peptide levels are dependent on loading conditions, more controlled physiologic data are needed. Accordingly, the aim of the current investigation was to study the natriuretic peptide axis in the context of a well‐controlled physiologic stimulus (intravenous saline infusion) in obese, otherwise healthy, individuals. This study design also enabled us to compare the relative effects of weight loss and intravenous saline infusion on circulating natriuretic peptide levels.

The evidence so far suggests that there may be some effect on cartilage and bone densities, and it is correlated with weight loss. I understand that there is no evidence to suggest that it stimulates the release of IGF-1, which is the mechanism via which growth hormone gets most of its purported performance enhancing effects (i.e. muscle bulk). Whilst this is a decent list of things to test if one is considering AOD9604 as simply a variant of growth hormone, it is by no means exhaustive of all the mechanisms via which a drug can enhance athletic performance. The evidence thus far suggests that AOD9604 could be performance enhancing, but there is nothing I would hang my hat on. That is why I maintain that Dank is more sorcerer than scientist.
Your level of physical activity also affects IGF-1, and heavy weight training for your legs is a particularly potent way to increase it. Some studies suggest that the effects of the popular anti-aging supplement DHEA actually arise due to this same type of increase in IGF-1 in the body that occurs with with weight training (so you choose: heavy barbell squats or a bottle of DHEA from the drugstore).
Twelve WT and 11 β3-KO male mice aged between 12 and 14 wk were used in the chronic administration study. The animals were housed individually in cages under the conditions described above. The animals were divided into three groups: WT [control (saline; n = 3); AOD (250 μg/kg·d; n = 4) and hGH (1 mg/kg·d; n = 5)] and β3-KO [control (saline; n = 3); AOD (250 μg/kg·d; n = 4); and hGH (1 mg/kg·d; n = 4)]. On d 0, all animals were anesthetized with sodium pentobarbitone and a collection of blood (200 μl) was taken in heparinized tubes (Terumo, Somerset, NJ) for glycerol determination. The plasma was isolated by centrifugation and stored at −20 C until required for analysis. For the following 28 d, the animals were given a single ip dose of compound at 0800 h each morning. Their food intake and body weight were recorded every second day and results expressed as a change from d 0. On d 28, the animals were anesthetized with sodium pentobarbitone, blood was collected for plasma glycerol determination, and they were then killed by a lethal injection of sodium pentobarbitone to the heart (35 mg/kg). Their white epididymal and brown subscapular adipose tissues were collected and weighed.
When it comes to losing weight, no matter how little amount, it’s an uphill struggle…all the way! Using peptides correctly will provide surprisingly good results if the user can also put in some effort from the very start. Just by reducing your food and calorie drinks along with some daily exercise will soon reward you with a noticeable decrease in weight and fat loss.
Peptide therapy, or the use of specific peptides in treatment, has gained great popularity in recent years. This is due largely to the fact that these peptides are highly specific (i.e., only do what you want them to do) while also being well-tolerated and safe. As of January 2015, there were over 60 US FDA-approved peptide medications, 140 peptide drugs being evaluated in clinical trials, and 500 in pre-clinical development.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Use only as directed. Consult your healthcare provider before using supplements or providing supplements to children under the age of 18. The information provided herein is intended for your general knowledge only and is not intended to be, nor is it, medical advice or a substitute for medical advice. If you have or suspect you have, a specific medical condition or disease, please consult your healthcare provider.
Human Growth Hormone (hGH) is not only important for growth processes during childhood, but plays a pivotal role in lipid metabolism throughout life. It is well known that hGH is involved in the regulation of lipolysis and lipogenesis. Therefore, hGH was implicated as a good potential candidate for the treatment of obesity. However undesired side effects, such as induction of glucose intolerance and insulin resistance, diabetes, acromegaly, cancer, edema, and hypertension [10-13] rendered therapeutic doses of hGH unsuitable for long-term treatments in humans.
Eligible study subjects were admitted after overnight fasting for an outpatient visit at the MGH CRC. Upon admission, two intravenous catheters were placed for phlebotomy and 10 mL/m2 of body‐surface area (BSA)/minute normal saline (0.9 mEq/mL) was infused over 2 hours. Blood pressure, heart rate, and oxygen saturation were measured every 20 minutes during the saline infusion. BSA was calculated according to the DuBois algorithm (BSA (in m2)=0.20247×height (m)0.725×weight (kg)0.425). Venous blood was sampled beginning immediately prior to the start of the infusion and at 40, 80, 120, and 180 minutes after the start of the infusion.
Some of these chains are pivotal in stimulating the release of natural human growth hormone (HGH), an element within the body that naturally declines significantly as we age. The hormone acts to repair and maintain our body, and as the levels of HGH reduce in our body the ability to fight aging, maintain vitality and manage our overall health declines.
Purchase Peptides Australia is an offshoot for driving peptide organizations in the perpetually developing industry of value peptide items, taking into account the necessities and requests of buyers all through the nation. The center estimations of our organization lies in the cooperations of just the most astounding nature of items that come in the most focused costs consolidated with a phenomenal and remarkable level of client administration conveyed by the designated peptide facility.
×